UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Diabetes Mellitus Type 2 and Abnormal Glucose Metabolism in the Setting of Human Immunodeficiency Virus

Endocrinology and metabolism clinics of North America, 2014-09, Vol.43 (3), p.685-696

2014

Volltextzugriff (PDF)

Sofosbuvir for treatment of chronic hepatitis C

Hepatology international, 2015-04, Vol.9 (2), p.161-173

2015

Volltextzugriff (PDF)

To Eliminate Hepatitis C in People Who Inject Drugs, Stop Ignoring Drug User Health

Clinical infectious diseases, 2021-07, Vol.73 (1), p.e119-e121

2021

Volltextzugriff (PDF)

Hospitalization is a missed opportunity for HIV screening, pre-exposure prophylaxis, and treatment

Addiction science & clinical practice, 2024-03, Vol.19 (1), p.22-5, Article 22

2024

Volltextzugriff (PDF)

PrEP Indications and PrEP Knowledge, Access, and Interest Among Individuals With HCV

Open forum infectious diseases, 2022-10, Vol.9 (10), p.ofac476-ofac476

2022

Volltextzugriff (PDF)

Safe and effective sofosbuvir-based therapy in patients with mental health disease on hepatitis C virus treatment

World journal of hepatology, 2016-11, Vol.8 (31), p.1318-1326

2016

Volltextzugriff (PDF)

Expanding the Evidence on Integrated Opioid Use Disorder and Infectious Disease Care

Journal of addiction medicine, 2021-11, Vol.15 (6), p.452-453

2021

Volltextzugriff (PDF)

Hepatitis C virus (HCV)-specific T cell confer resistance to HCV re-infection after sustained virologic response in a non-cytolytic fashion among people who inject drugs: results from ANCHOR study

Journal of hepatology, 2022-07, Vol.77, p.S571

2022

Volltextzugriff (PDF)

Opioids and Infectious Diseases: A Converging Public Health Crisis

The Journal of infectious diseases, 2019-07, Vol.220 (3), p.346-349

2019

Volltextzugriff (PDF)

Long-term outcomes associated with task-shifting of HCV treatment by non-specialist providers: five year follow-up from the ASCEND cohort

Journal of hepatology, 2022-07, Vol.77, p.S574

2022

Volltextzugriff (PDF)

Concurrent Initiation of Hepatitis C and Opioid Use Disorder Treatment in People Who Inject Drugs

Clinical infectious diseases, 2020-10, Vol.71 (7), p.1715-1722

2020

Volltextzugriff (PDF)

Diabetes Mellitus Type II and Abnormal Glucose Metabolism in the setting of HIV

Endocrinology and metabolism clinics of North America, 2014-09, Vol.43 (3), p.685-696

2014

Volltextzugriff (PDF)

Association of sustained virologic response with measures of direct-acting antiviral adherence in patients with Hepatitis C: data from the ASCEND and ANCHOR investigations

Journal of hepatology, 2022-07, Vol.77, p.S552

2022

Volltextzugriff (PDF)

Expansion of Treatment for Hepatitis C Virus Infection

Annals of internal medicine, 2018-03, Vol.168 (6), p.457

2018

Volltextzugriff (PDF)

Diabetes Mellitus Type 2 and Abnormal Glucose Metabolism in the Setting of Human Immunodeficiency Virus: HIV and Endocrine Disorders

Endocrinology and metabolism clinics of North America, 2014, Vol.43 (3)

2014

Volltextzugriff (PDF)

Dose‐specific clinical outcomes in patients with opioid use disorder treated with 24–32 mg/day of buprenorphine

Addiction (Abingdon, England), 2024-11, Vol.119 (11), p.1964-1972

2024

Volltextzugriff (PDF)

Dose‐specific clinical outcomes in patients with opioid use disorder treated with 24–32mg/day of buprenorphine

Addiction (Abingdon, England), 2024-11, Vol.119 (11), p.1964-1972

2024

Volltextzugriff (PDF)

“I got so much on my plate”: Understanding care discontinuity for HIV and HCV among formerly incarcerated persons

Health services research, 2023-08, Vol.58 (4), p.865-872

2023

Volltextzugriff (PDF)

A pilot study of safety and efficacy of HCV retreatment with sofosbuvir/velpatasvir/voxilaprevir in patients with or without HIV (RESOLVE STUDY)

Journal of hepatology, 2019-09, Vol.71 (3), p.498-504

2019

Volltextzugriff (PDF)

No Improvement in Hemoglobin A1c Following Hepatitis C Viral Clearance in Patients With and Without HIV

The Journal of infectious diseases, 2017-12, Vol.217 (1), p.47-50

2017

Volltextzugriff (PDF)

HCV reinfection associated with IDU and cocaine use in a cohort of people with OUD: 4 Year follow-up data from the ANCHOR cohort

Journal of hepatology, 2022-07, Vol.77, p.S572

2022

Volltextzugriff (PDF)

Undertreatment of opioid use disorder in patients hospitalized with injection drug use-associated infections

AIDS (London), 2023-10, Vol.37 (12), p.1799-1809

2023

Volltextzugriff (PDF)

Mechanisms of neuropathogenesis in HIV and HCV: similarities, differences, and unknowns

Journal of neurovirology, 2018-12, Vol.24 (6), p.670-678

2018

Volltextzugriff (PDF)

Clinical Laboratory Testing in the Era of Directly Acting Antiviral Therapies for Hepatitis C

Clinical microbiology reviews, 2017-01, Vol.30 (1), p.23-42

2017

Volltextzugriff (PDF)

Testosterone in Men With Chronic Hepatitis C Infection and After Hepatitis C Viral Clearance

Clinical infectious diseases, 2019-08, Vol.69 (4), p.571-576

2019

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Aktive Filter

ThemaDrug Therapy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(44)

Publikationsform

Artikel
(57)

Sprache

Englisch
(57)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Diabetes Mellitus Type 2 and Abnormal Glucose Metabolism in the Setting of Human Immunodeficiency Virus

Sofosbuvir for treatment of chronic hepatitis C

To Eliminate Hepatitis C in People Who Inject Drugs, Stop Ignoring Drug User Health

Hospitalization is a missed opportunity for HIV screening, pre-exposure prophylaxis, and treatment

PrEP Indications and PrEP Knowledge, Access, and Interest Among Individuals With HCV

Safe and effective sofosbuvir-based therapy in patients with mental health disease on hepatitis C virus treatment

Expanding the Evidence on Integrated Opioid Use Disorder and Infectious Disease Care

Hepatitis C virus (HCV)-specific T cell confer resistance to HCV re-infection after sustained virologic response in a non-cytolytic fashion among people who inject drugs: results from ANCHOR study

Opioids and Infectious Diseases: A Converging Public Health Crisis

Long-term outcomes associated with task-shifting of HCV treatment by non-specialist providers: five year follow-up from the ASCEND cohort

Concurrent Initiation of Hepatitis C and Opioid Use Disorder Treatment in People Who Inject Drugs

Diabetes Mellitus Type II and Abnormal Glucose Metabolism in the setting of HIV

Association of sustained virologic response with measures of direct-acting antiviral adherence in patients with Hepatitis C: data from the ASCEND and ANCHOR investigations

Expansion of Treatment for Hepatitis C Virus Infection

Diabetes Mellitus Type 2 and Abnormal Glucose Metabolism in the Setting of Human Immunodeficiency Virus: HIV and Endocrine Disorders

Dose‐specific clinical outcomes in patients with opioid use disorder treated with 24–32 mg/day of buprenorphine

Dose‐specific clinical outcomes in patients with opioid use disorder treated with 24–32mg/day of buprenorphine

“I got so much on my plate”: Understanding care discontinuity for HIV and HCV among formerly incarcerated persons

A pilot study of safety and efficacy of HCV retreatment with sofosbuvir/velpatasvir/voxilaprevir in patients with or without HIV (RESOLVE STUDY)

No Improvement in Hemoglobin A1c Following Hepatitis C Viral Clearance in Patients With and Without HIV

HCV reinfection associated with IDU and cocaine use in a cohort of people with OUD: 4 Year follow-up data from the ANCHOR cohort

Undertreatment of opioid use disorder in patients hospitalized with injection drug use-associated infections

Mechanisms of neuropathogenesis in HIV and HCV: similarities, differences, and unknowns

Clinical Laboratory Testing in the Era of Directly Acting Antiviral Therapies for Hepatitis C

Testosterone in Men With Chronic Hepatitis C Infection and After Hepatitis C Viral Clearance

Aktive Filter

Suchergebnisse filtern